Semiautomatic Aerosol Propellant Filler
75F40126Q00231
The U.S. Food and Drug Administration requires the purchase, delivery, installation, validation support, training, and warranty of a Semiautomatic Aerosol Propellant Filler for pMDI Two-Stage Formulation. This equipment supports FDA research in advanced pharmaceutical manufacturing and inhalation drug delivery systems. All questions must be submitted in writing by June 15, 2026, at 9:00 AM Eastern Time. Quotations are due by June 22, 2026, at 11:00 AM Eastern Time. The location for performance of services is not specified.